Compare UMH & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UMH | SDGR |
|---|---|---|
| Founded | 1968 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 2020 |
| Metric | UMH | SDGR |
|---|---|---|
| Price | $15.88 | $18.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $17.75 | ★ $26.25 |
| AVG Volume (30 Days) | 641.3K | ★ 813.3K |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | ★ 5.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | $256,272,000.00 | ★ $256,951,000.00 |
| Revenue This Year | $10.80 | $23.69 |
| Revenue Next Year | $8.34 | $20.46 |
| P/E Ratio | $203.10 | ★ N/A |
| Revenue Growth | 8.96 | ★ 32.90 |
| 52 Week Low | $13.95 | $15.99 |
| 52 Week High | $19.75 | $28.47 |
| Indicator | UMH | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 64.38 | 55.60 |
| Support Level | $14.96 | $17.53 |
| Resistance Level | $15.51 | $18.28 |
| Average True Range (ATR) | 0.25 | 0.68 |
| MACD | 0.08 | 0.23 |
| Stochastic Oscillator | 85.60 | 83.04 |
UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.